Dividends CalendarEarnings Calendar

ATLN.ZU | Actelion Ltd

Category: Healthcare

    Quick infos

      Trade prices

      • Volume:
      • Market Cap: 29.32B
      • Prev closed:
      • Open:
      • High:
      • Low:
      • 52 week low:
      • 52 week high:
      • Dividends:

      Top Stories (ATLN.ZU)

        About the Company

        Actelion is a pharmaceuticals and bio-technology company established in December 1997, headquartered in Allschwil near Basel in Switzerland. Its CEO and co-founder is cardiologist Jean-Paul Clozel. Actelion specializes in orphan diseases.

        Earnings History

        Date EPS / Forecast Revenue / Forecast
        February 12, 2019- / -- / -
        October 18, 2018- / -- / -
        July 19, 2018- / -- / -
        April 19, 2018- / -- / -
        February 13, 2018- / -- / -
        view more

        SWX - Swiss Exchange (SIX)

        ATLN.ZU Dividends

        Ex-Dividend Amount Announced Date Record Date Payment Date
        May 9, 20161.5May 11, 2016
        May 12, 20151.3May 15, 2015
        view more

        Key Persons

        • CEO :  Jean-Paul Clozel, MD

        Talk about Actelion Ltd below in comments section below.

        Do you think you'll buy? Do you already have active trades now?

        EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
        This profile is based on publicly available information and is intended to be informative in nature.

        Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.

        Jump to (Finance sites)

        Support this project

        If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
        More features coming soon :)

        Social Media 

        Recommended Books

        Investing For Dummies
        Buy on Amazon

        In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.